Osseus Preps for Post Coronavirus Surgical Demand

DALLAS, April 2, 2020 – Osseus Fusion Systems announces it has reached strategic agreements with its primary manufacturing and 3D printing partners to advance its portfolio of spinal fusion and fixation products.  In a statement, CEO Robert Pace, said “Although we are in unsettling times, the healthy structure of our organization and strength of our partnerships with our top contract manufacturers allows us a unique opportunity to take advantage of open capacity and structure long-term plans to round out the systems in our portfolio.  At the same time, we are excited that our demand allows us to keep our partnerships strong and people in our specialized industry working.  We are confident that these hard times will soon subside and want to be prepared for the inevitable backlog of critical surgical procedures.” 

About Osseus:

Osseus was founded in 2012, and is based in Dallas, Texas. Osseus is an innovative medical device firm focused on developing advanced technology products for minimally invasive surgery. Its team of visionary product developers and forward-thinking surgeons push the boundaries of device development, creating unique products that make surgeries more successful, help patients recover faster, and improve healthcare outcomes. For more information about Osseus, please visit www.osseus.com.

Mike Adams

Mike Adams is a medical device sales leader with extensive clinical experience in spine and biologics and a nationwide distribution network built over the last 10+ years in the industry. He has held various leadership positions in healthcare and device including Distributor Partner, Hospital COO and Spine VP of Sales. He currently leads the commercialization strategy for OrthoSpine Partners and is a Distributor Principal at Novel Medical. Because of his unique career path, Mike has the ability to see the healthcare business from multiple perspectives making him passionate about building strategic partnerships that help reduce overall costs, drive innovation, and cultivate growth for new markets.

Related Articles

One Comment

Back to top button